Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dinoprostone, quantity: 0.6667 mg/g - gel - excipient ingredients: colloidal anhydrous silica; triacetin - for induction of labour in term or near-term pregnant women who have favourable induction features. indications as at 27 august 2003: induction of labour in term or near-term pregnant women who have favourable induction features; and who have singleton pregnancy with a vertex presentation.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dinoprostone, quantity: 0.3333 mg/g - gel - excipient ingredients: colloidal anhydrous silica; triacetin - for induction of labour in term or near-term pregnant women who have favourable induction features. indications as at 27 august 2003: induction of labour in term or near-term pregnant women who have favourable induction features; and who have singleton pregnancy with a vertex presentation.

Armenien - Englisch - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sopharma jsc - metamizole (metamizole sodium), triacetonamine 4-toluensulfonate - tablets film-coated - 500mg+ 20mg

Armenien - Englisch - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sopharma jsc - metamizole (metamizole sodium), triacetonamine 4-toluensulfonate - tablets film-coated - 500mg+ 20mg

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - paracetamol 500mg;  ;  ;  ;  ;  ;  ; paracetamol 500mg - film coated tablet - 500 mg - active: paracetamol 500mg             excipient: calcium phosphate as sodium bicarbonate ffq carnauba wax hypromellose as opadry ii-22-7719. macrogol 8000 as opadry ii-22-7719. magnesium stearate maize starch microcrystalline cellulose polydextrose potassium sorbate povidone pregelatinised maize starch purified water sodium bicarbonate as sodium bicarbonate ffq titanium dioxide as opadry ii-22-7719. triacetin as opadry ii-22-7719. active: paracetamol 500mg excipient: carnauba wax colloidal silicon dioxide hypromellose as opadry ii-22-7719. macrogol 8000 as opadry ii-22-7719. magnesium stearate maize starch microcrystalline cellulose polydextrose povidone pregelatinised maize starch purified water sodium bicarbonate sodium starch glycolate titanium dioxide as opadry ii-22-7719. triacetin as opadry ii-22-7719. - for fast relief of acute pain. fast effective temporary relief of pain and discomfort associated with headache/tension headache, migraine headache, toothache, muscular aches, cold and flu symptoms, sore throat and period pain. helps reduce fever.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - paracetamol 500mg;  ;  ; paracetamol 500mg - film coated tablet - 500 mg - active: paracetamol 500mg     excipient: calcium phosphate as sodium bicarbonate fcc carnauba wax hypromellose as opadry ii-22-7719 macrogol 8000 as opadry ii-22-7719 magnesium stearate maize starch microcrystalline cellulose polydextrose as opadry ii-22-7719 potassium sorbate povidone pregelatinised maize starch purified water sodium bicarbonate as sodium bicarbonate fcc titanium dioxide as opadry ii-22-7719 triacetin as opadry ii-22-7719 active: paracetamol 500mg excipient: carnauba wax colloidal silicon dioxide hypromellose as opadry ii-22-7719 macrogol 8000 as opadry ii-22-7719 magnesium stearate maize starch microcrystalline cellulose polydextrose as opadry ii-22-7719 povidone pregelatinised maize starch purified water sodium bicarbonate sodium starch glycolate titanium dioxide as opadry ii-22-7719 triacetin as opadry ii-22-7719 - for fast relief of acute pain. fast effective temporary relief of pain and discomfort associated with headache/tension headache, migraine headache, toothache, muscular aches, cold and flu symptoms, sore throat and period pain. helps reduce fever.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - tadalafil -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - tadalafil -

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

viatris limited - ciprofloxacin hydrochloride 111mg equivalent to ciprofloxacin 100 mg (anhydrous);  ;   - film coated tablet - 100 mg - active: ciprofloxacin hydrochloride 111mg equivalent to ciprofloxacin 100 mg (anhydrous)     excipient: colloidal silicon dioxide crospovidone hypromellose macrogols magnesium stearate maize starch microcrystalline cellulose opadry white y-22-7719 polydextrose pregelatinised maize starch purified water titanium dioxide triacetin - for complicated urinary tract infections or pyelonephritis due to e.coli in paediatric patients aged 1-17 years. the risk-benefit assessment indicates that administration of ciprofloxacin to paediatric patients is appropriate. treatment should only be initiated after careful benefit/risk evaluation, due to possible adverse events related to joints/surrounding tissues. the use of ciprofloxacin for other indications is not recommended in children.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

viatris limited - ciprofloxacin hydrochloride 277.5mg equivalent to ciprofloxacin 250 mg (anhydrous);   - film coated tablet - 250 mg - active: ciprofloxacin hydrochloride 277.5mg equivalent to ciprofloxacin 250 mg (anhydrous)   excipient: colloidal silicon dioxide crospovidone hypromellose macrogols magnesium stearate maize starch microcrystalline cellulose opadry white y-22-7719 polydextrose pregelatinised maize starch purified water titanium dioxide triacetin - for complicated urinary tract infections or pyelonephritis due to e.coli in paediatric patients aged 1-17 years. the risk-benefit assessment indicates that administration of ciprofloxacin to paediatric patients is appropriate. treatment should only be initiated after careful benefit/risk evaluation, due to possible adverse events related to joints/surrounding tissues. the use of ciprofloxacin for other indications is not recommended in children.